Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Abstract B005: BMP signaling determines neuroblastoma sensitivity to retinoic acid by directing cell fate

Min Pan, Yinwen Zhang, William C. Wright, Hyeong-Min Lee, Richard H. Chapple, Xueying Liu, Jonathan Low, Duane Currier, Allister J. Loughran, Michael A. Dyer, Shondra M. Pruett, Burgess Freeman, III, Taosheng Chen, Brian J. Abraham, Elizabeth Stewart, John Easton, Paul Geeleher

Cancer Res (2024) 84 (17_Supplement): B005.

https://doi.org/10.1158/1538-7445.PEDIATRIC24-B005

Published: 05 September 2024

View articletitled, Abstract B005: BMP signaling determines neuroblastoma sensitivity to retinoic acid by directing cell fate

Journal Articles

Abstract B006: An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programs

Cancer Res (2024) 84 (17_Supplement): B006.

https://doi.org/10.1158/1538-7445.PEDIATRIC24-B006

Published: 05 September 2024

View articletitled, Abstract B006: An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programs

Journal Articles

Abstract 868: A novel unsupervised machine learning model applied to neuroblastoma single-cell RNA-seq data reveals a drug-induced mesenchymal-like gene expression program

Cancer Res (2024) 84 (6_Supplement): 868.

https://doi.org/10.1158/1538-7445.AM2024-868

Published: 22 March 2024

View articletitled, Abstract 868: A novel unsupervised machine learning model applied to neuroblastoma single-cell RNA-seq data reveals a drug-induced mesenchymal-like gene expression program

Journal Articles

Abstract 4665: Enhancing preclinical testing of agents in patient-derived pediatric solid tumor orthotopic xenografts with pharmacokinetics

Burgess B. Freeman, Kaley Blankenship, Michael A. Dyer, Elizabeth Stewart

Cancer Res (2023) 83 (7_Supplement): 4665.

https://doi.org/10.1158/1538-7445.AM2023-4665

Published: 04 April 2023

View articletitled, Abstract 4665: Enhancing preclinical testing of agents in patient-derived pediatric solid tumor orthotopic xenografts with pharmacokinetics

Journal Articles

Abstract 2289: Empowering point-and-click genomic analysis with large pediatric genomic reference data on St. Jude Cloud

Andrew Thrasher, Michael Macias, Alexander M. Gout, Delaram Rahbarinia, Xin Zhou, Samuel W. Brady, Clay McLeod, Michael C. Rusch, Xiaolong Chen, Soheil Meshinchi, Michael A. Dyer, Suzanne J. Baker, Martine F. Roussel, Jinghui Zhang

Cancer Res (2021) 81 (13_Supplement): 2289.

https://doi.org/10.1158/1538-7445.AM2021-2289

Published: 01 July 2021

View articletitled, Abstract 2289: Empowering point-and-click genomic analysis with large pediatric genomic reference data on St. Jude Cloud

Journal Articles

Abstract 6149: An innovative integrated cloud-based data portal for orthotopic patient-derived xenografts (O-PDX) available through the Childhood Solid Tumor Network (CSTN)

Cancer Res (2020) 80 (16_Supplement): 6149.

https://doi.org/10.1158/1538-7445.AM2020-6149

Published: 15 August 2020

View articletitled, Abstract 6149: An innovative integrated cloud-based data portal for orthotopic patient-derived xenografts (O-PDX) available through the Childhood Solid Tumor Network (CSTN)

Journal Articles

Abstract LB-074: Antigen-cross presentation promotes development of terminally differentiated CD8 T cells in young individuals

Ardiana Moustaki, Jeremy Chase Crawford, Shanta Alli, Anthony Zamora, Yiping Fan, Shannon Boi, Natalie M. McDonald, Paul G. Thomas, Alberto S. Pappo, Michael A. Dyer, Elizabeth Stewart, Sara Federico, Ben Youngblood

Cancer Res (2020) 80 (16_Supplement): LB-074.

https://doi.org/10.1158/1538-7445.AM2020-LB-074

Published: 15 August 2020

View articletitled, Abstract LB-074: Antigen-cross presentation promotes development of terminally differentiated CD8 T cells in young individuals

Journal Articles

Abstract 6144: St. Jude Pediatric Brain Tumor Portal: Cloud-based resource for patient-derived orthotopic xenograft (PDOX) models of pediatric high-grade glioma, ependymoma, and CNS embryonal tumors

Cancer Res (2020) 80 (16_Supplement): 6144.

https://doi.org/10.1158/1538-7445.AM2020-6144

Published: 15 August 2020

View articletitled, Abstract 6144: St. Jude Pediatric Brain Tumor Portal: Cloud-based resource for patient-derived orthotopic xenograft (PDOX) models of pediatric high-grade glioma, ependymoma, and CNS embryonal tumors

Journal Articles

Abstract IA18: MYCN amplification and ATRX mutations are incompatible in neuroblastoma

Maged Zeineldin, Sara Federico, Xiang Chen, Beisi Xu, Elizabeth Stewart, Arlene Naranjo, Michael D. Hogarty, Michael A. Dyer

Cancer Res (2018) 78 (19_Supplement): IA18.

https://doi.org/10.1158/1538-7445.PEDCA17-IA18

Published: 01 October 2018

View articletitled, Abstract IA18: MYCN amplification and ATRX mutations are incompatible in neuroblastoma

Journal Articles

Abstract PR11: Synthetic lethality between ATRX mutations and MYCN amplification in neuroblastoma

Maged Zeineldin, Sara M. Federico, Lyra Griffith, Jongyre Jeon, Xiang Chen, John Easton, Jianrong Wu, Shenghua Mao, Yanling Liu, Arlene Naranjo, Alberto S. Pappo, Michael D. Hogarty, Michael A. Dyer

Cancer Res (2018) 78 (19_Supplement): PR11.

https://doi.org/10.1158/1538-7445.PEDCA17-PR11

Published: 01 October 2018

View articletitled, Abstract PR11: Synthetic lethality between ATRX mutations and MYCN amplification in neuroblastoma

Journal Articles

Abstract A09: Preclinical trial using the combination of panobinostat with bortezomib in human orthotopic xenograft mouse models of rhabdomyosarcoma

Elizabeth Stewart, Cori Bradley, Anang Shelat, Alberto Pappo, Michael A. Dyer

Cancer Res (2016) 76 (5_Supplement): A09.

https://doi.org/10.1158/1538-7445.PEDCA15-A09

Published: 04 April 2016

View articletitled, Abstract A09: Preclinical trial using the combination of panobinostat with bortezomib in human orthotopic xenograft mouse models of rhabdomyosarcoma

Journal Articles

Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer

David M. Langenau, Alejandro Sweet-Cordero, Robert J. Wechsler-Reya, Michael A. Dyer

Cancer Res (2015) 75 (24): 5176–5186.

https://doi.org/10.1158/0008-5472.CAN-15-1308

Published: 14 December 2015

View articletitled, Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer

Journal Articles

Abstract IA05: Targeting the oxidative stress pathway in rhabdomyosarcoma

Michael A. Dyer

Cancer Res (2014) 74 (20_Supplement): IA05.

https://doi.org/10.1158/1538-7445.PEDCAN-IA05

Published: 09 October 2014

View articletitled, Abstract IA05: Targeting the oxidative stress pathway in rhabdomyosarcoma

Journal Articles

Abstract 3109: ALK as a valid therapeutic target for the treatment of rhabdomyosarcoma

Monika Wierdl, Lyudmila Tsurkan, Viktor Tollemar, Lying Chi, Elizabeth Stewart, Michael A. Dyer, Philip M. Potter

Cancer Res (2014) 74 (19_Supplement): 3109.

https://doi.org/10.1158/1538-7445.AM2014-3109

Published: 01 October 2014

View articletitled, Abstract 3109: ALK as a valid therapeutic target for the treatment of rhabdomyosarcoma

Journal Articles

Abstract 4873: Comprehensive analysis of 160 whole-genome sequences reveals striking telomere alteration patterns in 9 pediatric cancers

Matthew D. Parker, Gang Wu, Xiang Chen, Michael Rusch, Armita Bahrami, Li Ding, Elaine Mardis, Charles Mullighan, Richard Gilbertson, Michael A. Dyer, Richard K. Wilson, James Downing, Jinghui Zhang

Cancer Res (2012) 72 (8_Supplement): 4873.

https://doi.org/10.1158/1538-7445.AM2012-4873

Published: 15 April 2012

View articletitled, Abstract 4873: Comprehensive analysis of 160 whole-genome sequences reveals striking telomere alteration patterns in 9 pediatric cancers

Journal Articles

Targeting the p53 Pathway in Retinoblastoma with Subconjunctival Nutlin-3a

Rachel C. Brennan, Sara Federico, Cori Bradley, Jiakun Zhang, Jacqueline Flores-Otero, Matthew Wilson, Clinton Stewart, Fangyi Zhu, Kip Guy, Michael A. Dyer

Cancer Res (2011) 71 (12): 4205–4213.

https://doi.org/10.1158/0008-5472.CAN-11-0058

Published: 14 June 2011

View articletitled, Targeting the p53 Pathway in Retinoblastoma with Subconjunctival Nutlin-3a

Includes: Supplementary data

Journal Articles

Abstract SY15-02: Comprehensive analysis of genetic and epigenetic factors contributing to tumorigenesis in retinoblastoma

Michael A. Dyer

Cancer Res (2011) 71 (8_Supplement): SY15-02.

https://doi.org/10.1158/1538-7445.AM2011-SY15-02

Published: 15 April 2011

View articletitled, Abstract SY15-02: Comprehensive analysis of genetic and epigenetic factors contributing to tumorigenesis in retinoblastoma

Journal Articles

Retinoblastoma: From the Two-Hit Hypothesis to Targeted Chemotherapy

David MacPherson, Michael A. Dyer

Cancer Res (2007) 67 (16): 7547–7550.

https://doi.org/10.1158/0008-5472.CAN-07-0276

Published: 15 August 2007

View articletitled, Retinoblastoma: From the Two-Hit Hypothesis to Targeted Chemotherapy

Journal Articles

Neuronal Differentiation and Synaptogenesis in Retinoblastoma

Dianna A. Johnson, Jiakun Zhang, Sharon Frase, Matthew Wilson, Carlos Rodriguez-Galindo, Michael A. Dyer

Cancer Res (2007) 67 (6): 2701–2711.

https://doi.org/10.1158/0008-5472.CAN-06-3754

Published: 15 March 2007

View articletitled, Neuronal Differentiation and Synaptogenesis in Retinoblastoma

Includes: Supplementary data

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract B005: BMP signaling determines neuroblastoma sensitivity to retinoic acid by directing cell fate

Abstract B006: An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programs

Abstract 868: A novel unsupervised machine learning model applied to neuroblastoma single-cell RNA-seq data reveals a drug-induced mesenchymal-like gene expression program

Abstract 4665: Enhancing preclinical testing of agents in patient-derived pediatric solid tumor orthotopic xenografts with pharmacokinetics

Abstract 2289: Empowering point-and-click genomic analysis with large pediatric genomic reference data on St. Jude Cloud

Abstract 6149: An innovative integrated cloud-based data portal for orthotopic patient-derived xenografts (O-PDX) available through the Childhood Solid Tumor Network (CSTN)

Abstract LB-074: Antigen-cross presentation promotes development of terminally differentiated CD8 T cells in young individuals

Abstract 6144: St. Jude Pediatric Brain Tumor Portal: Cloud-based resource for patient-derived orthotopic xenograft (PDOX) models of pediatric high-grade glioma, ependymoma, and CNS embryonal tumors

Abstract IA18: MYCN amplification and ATRX mutations are incompatible in neuroblastoma

Abstract PR11: Synthetic lethality between ATRX mutations and MYCN amplification in neuroblastoma

Abstract A09: Preclinical trial using the combination of panobinostat with bortezomib in human orthotopic xenograft mouse models of rhabdomyosarcoma

Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer

Abstract IA05: Targeting the oxidative stress pathway in rhabdomyosarcoma

Abstract 3109: ALK as a valid therapeutic target for the treatment of rhabdomyosarcoma

Abstract 4873: Comprehensive analysis of 160 whole-genome sequences reveals striking telomere alteration patterns in 9 pediatric cancers

Targeting the p53 Pathway in Retinoblastoma with Subconjunctival Nutlin-3a

Abstract SY15-02: Comprehensive analysis of genetic and epigenetic factors contributing to tumorigenesis in retinoblastoma

Retinoblastoma: From the Two-Hit Hypothesis to Targeted Chemotherapy

Neuronal Differentiation and Synaptogenesis in Retinoblastoma

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only